Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Allergan scores an FDA OK for a new drug targeting night-time urination
Allergan scores an FDA OK for a new drug targeting night-time urination
Allergan scores an FDA OK for a new drug targeting night-time urination
Submitted by
admin
on March 6, 2017 - 9:42am
Source:
Endpoints
News Tags:
Allergan
FDA
night urination
SER-120
Noctiva
Serenity Pharmaceuticals
Headline:
Allergan scores an FDA OK for a new drug targeting night-time urination
Do Not Allow Advertisers to Use My Personal information
